Cargando…

Prevention of bone metatasis in prostate cancer by denosumab: Unneeded endpoint or unmet need?

Detalles Bibliográficos
Autor principal:	Ohlmann, Carsten-Henning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2012
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708206/ https://www.ncbi.nlm.nih.gov/pubmed/26813735 http://dx.doi.org/10.3978/j.issn.2223-4683.2012.05.09

Ejemplares similares

Denosumab: Delay of bone metastasis in men with nonmetastatic castrate-resistant prostate cancer
por: Manger, Jules P., et al.
Publicado: (2012)

Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab
por: Wolff, Johannes M., et al.
Publicado: (2012)

Heterophile Antibody Interference led to Unneeded Chemotherapy in a Testicular Cancer Patient
por: Soares, Daniele G., et al.
Publicado: (2016)

Risk vs. disease: the role of artificial intelligence in avoiding unneeded testing
por: Cademartiri, Filippo, et al.
Publicado: (2022)

Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Are Respectively Associated with Prognosis of Gastric Cancer with Liver Metatasis Undergoing and without Hepatectomy
por: Gao, Jialiang, et al.
Publicado: (2019)

The Positive Effects of Unneeded Consumption Behaviour on Consumers during the COVID-19 Pandemic
por: He, Jianjia, et al.
Publicado: (2021)

PMEPA1 guards against TGF-β-mediated prostate cancer bone metastasis
por: Blee, Alexandra M., et al.
Publicado: (2016)

Management of bone metastases in refractory prostate cancer – role of denosumab
por: Paller, Channing J, et al.
Publicado: (2012)

Unmet Needs and Perspectives in Oral Cancer Prevention
por: Bouaoud, Jebrane, et al.
Publicado: (2022)

Macrophages assemble! But do they need IL‐4R during schistosomiasis?
por: Rückerl, Dominik, et al.
Publicado: (2019)

Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
por: Rader, Michael, et al.
Publicado: (2012)

Preventing aggressive prostate cancer with proven cardiovascular disease preventive methods
por: Moyad, Mark A
Publicado: (2015)

Matrilin-2, an extracellular adaptor protein, is needed for the regeneration of muscle, nerve and other tissues
por: Korpos, Éva, et al.
Publicado: (2015)

Prevention of erectile dysfunction after radiotherapy for prostate cancer
por: Faiena, Izak, et al.
Publicado: (2014)

Unmet Needs in Preventive Treatment of Migraine
por: Bentivegna, Enrico, et al.
Publicado: (2023)

A case to be made: theoretical and empirical arguments for the need to consider fatigue in post-stroke motor rehabilitation
por: Sterr, Annette, et al.
Publicado: (2015)

Nomenclatural issues concerning cultured yeasts and other fungi: why it is important to avoid unneeded name changes
por: Yurkov, Andrey, et al.
Publicado: (2021)

Long-term survival of participants in the prostate cancer prevention trial
por: Silberstein, Jonathan L, et al.
Publicado: (2014)

Advances and Unmet Needs in the Therapeutics of Bone Fragility
por: Ramchand, Sabashini K., et al.
Publicado: (2018)

Deletional tolerance prevents AQP4‐directed autoimmunity in mice
por: Vogel, Anna‐Lena, et al.
Publicado: (2017)

Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
por: Schijns, Virgil, et al.
Publicado: (2020)

Re: Long-term survival of participants in the Prostate Cancer Prevention Trial
por: Thompson, Ian M, et al.
Publicado: (2014)

Unmet Medical Needs of Patients with Benign Prostate Enlargement
por: Lee, Munjae, et al.
Publicado: (2020)

The role of IL‐23 receptor signaling in inflammation‐mediated erosive autoimmune arthritis and bone remodeling
por: Razawy, Wida, et al.
Publicado: (2018)

The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs
por: Kouspou, Michelle M., et al.
Publicado: (2020)

Peripheral and systemic antigens elicit an expandable pool of resident memory CD8(+) T cells in the bone marrow
por: Pascutti, Maria Fernanda, et al.
Publicado: (2019)

Memory CD8(+) T cells colocalize with IL-7(+) stromal cells in bone marrow and rest in terms of proliferation and transcription
por: Sercan Alp, Özen, et al.
Publicado: (2015)

Expanding luminal epitheliums as cells of origin for prostate cancer
por: Gu, Yuexi, et al.
Publicado: (2021)

Does tadalafil prevent erectile dysfunction in patients undergoing radiation therapy for prostate cancer?
por: Incrocci, Luca
Publicado: (2014)

Combined immunotherapy for advanced prostate cancer: Empowering the T cell army
por: Suleman, Sufyan, et al.
Publicado: (2017)

Unmet need to screen for lead toxicity in the prevention of ADHD
por: Sahu, Suchanda, et al.
Publicado: (2021)

Genome interrupted: sequencing of prostate cancer reveals the importance of chromosomal rearrangements
por: Kumar, Akash, et al.
Publicado: (2011)

Plasma-seq: a novel strategy for metastatic prostate cancer analysis
por: Farris, Caitlin, et al.
Publicado: (2013)

Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer
por: Rhea, Logan P, et al.
Publicado: (2019)

Ailanthone: a new potential drug for castration-resistant prostate cancer
por: Peng, Shihong, et al.
Publicado: (2017)

Impact of denosumab on bone mass in cancer patients
por: Brown-Glaberman, Ursa, et al.
Publicado: (2013)

The urgent need to cut methane emissions
por: Nisbet, Euan G
Publicado: (2021)

Severe Hypocalcemia due to Denosumab in Metastatic Prostate Cancer
por: Muqeet Adnan, Mohammed, et al.
Publicado: (2014)

Future of bisphosphonates and denosumab for men with advanced prostate cancer
por: Iranikhah, Maryam, et al.
Publicado: (2014)

Unmet needs in Iranian cancer patients
por: Ramezanzade Tabriz, Elahe, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8cblnk2265gii6vrt6d16hmvnr